Discover

News & Info

Quote List Quote List

CANBRIDGE-B(01228.HK)

Event Tracking

Mar23

CANBRIDGE-B to Release FY2025 Earnings on March 30 During-Market (BJT), Forecast Revenue HKD 161.74 M, EPS HKD -0.826

01:10

Mar10

Nichi Xia Cheng B-Type Private Plc Issues 84,033,600 Shares to Wuxi Biologics HealthCare Venture

23:38

Feb15

Nordic Nanovector Raises Nearly HK$200 Million Through Rights Issue to WuXi Biologics

23:34

Dec8

BiochemChina's CAN 103 Included in Commercial Insurance Catalog and Officially Enters Clinical Use

10:17

Sep28

BioMedicines Biologics Concludes Share Subscription Underwriting Settlement for HK$22,591,400

10:19

Sep15

Concord Pharmaceutical Issues 9,996,200 Shares to 3 Subscribers

14:51

Schedules & Filings

Schedules

Filings

Mar30

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 15.42 M, Net Income -24.7 M, EPS -0.0517

Aug31

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 12.18 M, Net Income 32.42 M, EPS 0.0763

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 21.44 M, Net Income -103.91 M, EPS -0.2445

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More